{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:ERK",
      "entity_text" : "MAPK",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P04083",
      "entity_text" : "ANXA1",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "However, there is evidence to indicate that ANXA1 can inhibit cell proliferation, as demonstrated in the study by Alldridge and Bryant, who reported that ANXA1 activated the ERK1/2 and MAPK signal transduction pathways, thus destroying the cytoskeleton, inhibiting the expression of cyclin D1 and inhibiting cell proliferation.",
  "reading_complete" : "2020-08-03T17:47:57Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T17:47:01Z",
  "trigger" : "activated",
  "evidence" : [ "ANXA1 activated the ERK1/2 and MAPK" ],
  "pmc_id" : "5358711",
  "score" : 0
}